Sustained Adrenergic Activation of YAP1 Induces Anoikis Resistance in Cervical Cancer Cells

Yang Li; Shanshan Yang; Nouara C. Sadaoui; Wei Hu; Santosh K. Dasari; Lingegowda S. Mangala; Yunjie Sun; Shuangtao Zhao; Linghua Wang; Yuan Liu; Lois M. Ramondetta; Ke Li; Chong Lu; Yu Kang; Steve W. Cole; Susan K. Lutgendorf; Anil K. Sood

iScience (Jul 2020)

Sustained Adrenergic Activation of YAP1 Induces Anoikis Resistance in Cervical Cancer Cells

Yang Li,
Shanshan Yang,
Nouara C. Sadaoui,
Wei Hu,
Santosh K. Dasari,
Lingegowda S. Mangala,
Yunjie Sun,
Shuangtao Zhao,
Linghua Wang,
Yuan Liu,
Lois M. Ramondetta,
Ke Li,
Chong Lu,
Yu Kang,
Steve W. Cole,
Susan K. Lutgendorf,
Anil K. Sood

Affiliations

Yang Li: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Gynecologic Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
Shanshan Yang: Department of Gynecologic Radiotherapy, Harbin Medical University Cancer Hospital, Harbin, China
Nouara C. Sadaoui: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Wei Hu: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Santosh K. Dasari: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Lingegowda S. Mangala: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Yunjie Sun: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Shuangtao Zhao: Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Linghua Wang: Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Yuan Liu: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Lois M. Ramondetta: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Ke Li: Department of Obstetrics and Gynecology of Shanghai Medical School, Fudan University, Shanghai, China
Chong Lu: Department of Obstetrics and Gynecology of Shanghai Medical School, Fudan University, Shanghai, China
Yu Kang: Department of Obstetrics and Gynecology of Shanghai Medical School, Fudan University, Shanghai, China
Steve W. Cole: Cousins Center for Psychoneuroimmunology and Department of Psychiatry and Biobehavioral Sciences, Division of Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA
Susan K. Lutgendorf: Department of Psychological & Brain Sciences, Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Department of Urology, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA
Anil K. Sood: Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Corresponding author

Journal volume & issue: Vol. 23, no. 7
p. 101289

Abstract

Read online

Summary: Chronic stress-related hormones modulate tumor pathogenesis at multiple levels; however, the molecular pathways involved in stress and cervical cancer progression are not well understood. We established a preclinical orthotopic mouse model of cervical cancer and used the model to show that daily restraint stress increased tumor growth and metastatic tumor burden. Exposure to norepinephrine significantly protected cervical cancer cells from anoikis. We demonstrated that YAP1 was dephosphorylated and translocated from the cytoplasm to the nucleus by norepinephrine, a process initiated by ADRB2/cAMP/protein kinase A activation. Furthermore, anoikis resistance and YAP1 activation induced by norepinephrine could be rescued by a broad β-adrenergic receptor antagonist, propranolol. Collectively, our results provide a pivotal molecular pathway for disrupting pro-tumor neuroendocrine signaling in cervical cancer.

Published in iScience

ISSN: 2589-0042 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Science
Website: http://www.cell.com/iscience/home

About the journal

Abstract

Keywords